Cancer clinical trials in the region Normandie

143 currently recruiting clinical trials
Region Normandie

Phase 3 Lymphoma #NCT06006117 #2022-501810-77-00
B cell lymphoma Marginal zone lymphoma None > 60 ml/min 50-60 ml/min 30-50 ml/min 1 2 3 or more Monoclonal antibodies
Systemic Treatment-Naive Bispecific T-cell engager antibodies Allogeneic stem cell transplant
Centre Henri Becquerel (Rouen )
The Lymphoma Academic Research Organisation (LYSARC)
Phase 3 Lung cancer #NCT03774732 #2024-512173-27-00
NSCLC (Non-Small Cell Lung Cancer) Squamous NSCLC Non-squamous NSCLC Locally Advanced Metastatic PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None
ALK EGFR
Centre François Baclesse (Caen ), CHU Caen Normandie (Caen)
UNICANCER
Phase 3 Kidney cancer #NCT06364631 #2023-503317-29-00
Clear cell carcinoma Metastatic None 0 1 or 2 Systemic Treatment-Naive
Centre François Baclesse (Caen )
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3 Colon cancer Rectal cancer #NCT04120701 #2024-515297-27-00
Adenocarcinoma Localized Locally Advanced None Systemic Treatment-Naive Surgery Systemic Treatment-Naive Surgery
Chemotherapy Radiotherapy Chemotherapy Radiotherapy
Centre François Baclesse (Caen ), CHU Caen Normandie (Caen), Centre Hospitalier Universitaire de Rouen (Rouen), Centre Hospitalier Jacques Monod (Flers), Centre Hospitalier de Bayeux (Bayeux) (and 1 more...)
CHU Dijon
Phase 3 Breast cancer #NCT05232916 #2023-504323-25-01
HER2 Positive Localized Locally Advanced None Targeted therapy Targeted therapy
Systemic Treatment-Naive Systemic Treatment-Naive
Centre François Baclesse (Caen )
Greenwich LifeSciences, Inc.
Phase 3 Lung cancer #NCT06875310 #2024-515698-85-00
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced Metastatic KRAS G12C None Systemic Treatment-Naive
Targeted therapy Targeted therapy
Centre François Baclesse (Caen )
Mirati Thérapeutique Inc.
Phase 3 Breast cancer #NCT05696626 #2023-503708-10-00
HER2 Negative HR Positive Locally Advanced Metastatic ESR 1 2 Targeted therapy Hormone therapy
Other mutation Systemic Treatment-Naive
Centre François Baclesse (Caen ), Centre Henri Becquerel (Rouen )
Sermonix Pharmaceuticals Inc.
Phase 3 Prostate cancer #NCT05974774 #2023-506817-23-01
Metastatic Hormone-sensitive None Hormone therapy
Centre François Baclesse (Caen )
EORTC - Organisation Européenne pour la Recherche et le Traitement du Cancer
Phase 3 Breast cancer #NCT04862663 #2023-504997-39-00
HER2 Negative HR Positive Locally Advanced Metastatic 1 Hormone therapy
Centre Hospitalier Universitaire de Rouen (Rouen)
AstraZeneca
Phase 3 Prostate cancer #NCT06276465 #2023-507482-26-00
Adenocarcinoma Metastatic Castration-resistant None Surgery Radiotherapy Systemic Treatment-Naive
Immunotherapy Chemotherapy
Centre François Baclesse (Caen )
UNICANCER